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Abstract
Oral squamous cell carcinoma (OSCC) accounts for 5.8% of all malignancies in Taiwan and the incidence of OSCC is on the
rise. OSCC is also a common malignancy worldwide and the five-year survival rate remains poor. Therefore, new and
effective treatments are needed to control OSCC. In the present study we have investigated the efficacy and associated
mechanisms of polyenylpyrroles and their analogs in both in vitro cell culture and in vivo nude mice xenografts.
Auxarconjugatin B (compound 1a) resulted in cell cycle arrest in the G2/M phase and caspase-dependent apoptosis in OEC-
M1 and HSC-3 cells by activating DNA damage and mitochondria dysfunction through the loss of mitochondrial membrane
potential, release of cytochrome c, increase in B-cell lymphoma-2-associated X protein level, and decrease in B-cell
lymphoma-2 level. Compound 1a-induced generation of intracellular reactive oxygen species through cytochrome P450
1A1 was identified as a major mechanism of its effect for DNA damage, mitochondria dysfunction and apoptosis, which was
reversed by antioxidant N-acetylcysteine as well as cytochrome P450 1A1 inhibitor and specific siRNA. Furthermore,
compound 1a-treated nude mice showed a reduction in the OEC-M1 xenograft tumor growth and an increase in the
caspase-3 activation in xenograft tissue. These results provide promising insights as to how compound 1a mediates
cytotoxicity and may prove to be a molecular rationale for its translation into a potential therapeutic against OSCC.
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Introduction
According to the latest report from the Department of Health,
Executive Yuan, Taiwan, oral cancer affects a significant number
of patients in their economically productive age and approxi-
mately 2300 men in Taiwan with an average age of 58.3 years
succumb to oral cancer every year. Oral cancer is also a common
malignancy worldwide and the incidence of oral cancer continues
to increase annually [1]. The usual therapy for oral cancer involves
one or more of the following modalities: surgery, chemotherapy
and radiotherapy. Unfortunately, despite advances in clinical
management, the survival rate remains poor [2,3]. This strongly
underlines the importance of discovering and developing new and
effective treatments to improve the prognosis of oral cancer
patients.
Apoptosis is one of the important mechanisms of anticancer
drug-mediated cell death. It is induced by two major pathways:
mitochondrial (intrinsic) pathway and death receptor (extrinsic)
pathway. Mitochondrial pathway is activated by the release of
proapoptotic factors, such as cytochrome c and apoptotic inducing
factor, from the mitochondria into the cytosol. The mitochondrial
outer membrane permeability is regulated by the Bcl-2 family
proteins, which are the central regulator of cytochrome c release
and caspases activation [4]. After being released from the
mitochondria, cytochrome c can bind to dATP and apoptotic
protease-activating factor-1 which results in the activation of
caspase-9 and caspase-3. Activated caspase-3 cleaves various
substrates, including poly (ADP-ribose) polymerase (PARP), a
DNA repair enzyme, thus leading to inevitable cell death [5].
Death receptor pathway involves the Fas and other members of
the tumor-necrosis factor receptor family that triggers caspase-8
activation [6]. Caspase-8 directly activates caspase-3 and cleaves
Bid, which then triggers the mitochondrial pathway [7]. Reactive
oxygen species (ROS) generation has usually been observed during
the process of apoptosis in cells subjected to anticancer drugs
treatment [8]. Increased ROS level might lead to DNA damage
and these damaged cells subsequently undergo either cell cycle
arrest to facilitate DNA repair, or induce apoptosis to eliminate the
excessively damaged cells [9]. DNA damage might activate p53-
dependent apoptosis through inhibiting both the G1/S and the
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G2/mitosis (M) transitions by directly stimulating the expression of
p21WAF1/CIP1, an inhibitor of cyclin-dependent kinases (Cdks)
[10]. DNA damage might also activate protein kinases ATM and
ATR which subsequently triggers the activation of the protein
kinases Chk1 and Chk2, which in turn inhibits Cdc2 by
inactivating Cdc25, the phosphatase that normally activates
Cdc2 [11].
Conjugated polyenes is an interesting class of widely occurring
natural products which have been shown to possess excellent
biological properties including antitumor activities [12]. However,
the typically small quantities that can be obtained from the
isolation of natural sources (fungi or bacteria) often limit its
applications. To address this limitation as well as to provide access
to structurally diverse analogs of these compounds, we have
developed a synthetic strategy that allows conjugated polyenes to
be synthesized expediently. In our previous study a class of
polyenylpyrroles and their analogs were designed from a hit
compound identified in a fungus and compound 1g was identified
as a potent anti-cancer agent against human non-small cell lung
carcinoma cell lines A549 [13]. In this study, the compounds
synthesized were evaluated for their cell cytotoxicity to four
human oral squamous cell carcinoma cell lines.
Materials and Methods
Cell Lines and Reagents
The backbone of the synthesized polyenylpyrroles was shown in
Fig. 1 [13]. OEC-M1 and SAS cell lines were provided by Prof.
Tzong-Ming Shieh, China Medical University [14,15]. HSC-3 cell
line was obtained from the Japanese Collection of Research
Bioresources. SCC-4 cell line was obtained from ATCC (Manas-
sas, VA, USA). OEC-M1 and HSC-3 cells were cultured in RPMI
1640 medium; SAS and SCC-4 cells were cultured in MEM-F12
and DMEM medium respectively. All cells were cultured under
standard conditions. 29,79-dichlorofluorescein diacetate and 3,39-
diethyloxacarbocyanine iodide (DiOC2(3)) were obtained from
Molecular Probes (Eugene, OR). Antibodies against caspase-8,
PARP, Bcl-2, Bax, Bak, and actin were purchased from Chemicon
(Temecula, CA). Antibodies against p-cdc2, cyclin B1, p-chk2,
p53, p21, and CYP1A1 were obtained from Santa Cruz
Biotechnology Inc (Santa Cruz, CA). Antibodies against caspase-
3 and caspase-9 were purchased from R&D Systems (Minneapolis,
MN). Antibody against VDAC (anti-porin) was purchased from
EMD Millipore (Billerica, MA). All other chemicals were obtained
from Sigma Chemical Co. (St. Louis, MO).
In vitro Growth Inhibition Assay
Cells were cultured for 24 and 48 h in 96 wells plate containing
media which comprise the tested compound and a final DMSO
concentration of 0.1%. Thereafter, 10 ml AlamarBlueH reagent
(AbD Serotec, Oxford, U.K.) was added into each well and the
cells were further incubated at 37uC for 6 h. The cell viability was
determined by the fluorescence intensity detected at 570 nm and
600 nm.
Cell Cycle Determination and TdT End-labeling Assay
DNA content and cell cycle distribution were analyzed using a
Becton Dickinson FACScan Plus flow cytometer. Cytofluoro-
metric analysis was performed using a CellQuestR (Becton
Dickinson, San Jose, CA), on a minimum of 10000 cells per
sample. Apoptosis was assayed by a TdT-mediated dUTP Nick-
End Labeling assay and measured by the FACScan system [13].
Detection of Mitochondrial Cytochrome C Release
By flow cytometry method: Cells (16105) were harvested,
treated with 100 ml digitonin (50 mg/ml in PBS with 100 mM
KCl) for 5 min on ice (until .95% were permeabilized as assessed
by trypan blue exclusion), and fixed in 4% paraformaldehyde for
20 min at room temperature. After which, the cells were washed
three times in PBS, incubated in blocking buffer (3% BSA, 0.05%
saponin in PBS) for 1 h and stained with 1 mg anti-cytochrome c
antibody (Chemicon, Temecula, CA) overnight at 4uC. Thereaf-
ter, the cells were further washed three times and incubated with
1:200 FITC-labeled secondary antibody for 1 h at room temper-
ature. Cells were analyzed by flow cytometry. By western blotting
method: cells with or without treatment were harvested by
centrifugation at 6006g for 10 min. After washing once with ice-
cold PBS, cell pellets were resuspended in buffer A (20 mM
HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na-
EDTA, 1 mM Na-EGTA, 1 mM dithiothreitol, 0.1 mM phenyl-
methylsulfonyl fluoride containing 250 mM sucrose). After being
chilled on ice for 30 min, the cells were disrupted by 15 strokes of
a glass homogenizer. The homogenate was centrifuged twice to
remove unbroken cells and nuclei (7506g, 10 min, 4uC). The
supernatant was then obtained by centrifugation at 100006g for
60 min at 4uC. The resulting pellets were identified as the
mitochondrial fraction, and supernatants were identified as
cytosolic fraction. All steps were performed on ice or 4uC.
Cytochrome c release into the cytosolic fraction for each condition
was assessed by western blotting analysis.
Measurement of Mitochondrial Membrane Potential
(Dym)
A reduction in mitochondrial membrane potential was moni-
tored by DiOC2(3) staining and measured by flow cytometry [13].
Western Blotting Analysis and Reactive Oxygen Species
Detection
Whole cell lysates were prepared from DMSO- or compound
1a-treated cells and western blotting was performed following
earlier described methods [16]. Intracellular H2O2 was measured
by detecting the fluorescence intensity of 29,79-dichlorofluorescein,
the oxidation product of 29,79-dichlorofluorescein diacetate, as
described previously [17].
DNA Damage Assay
Genomic DNA isolation and the apurinic/apyrimidinic (AP)
sites of DNA lesions were analyzed as described previously [18].
The number of AP sites was assessed using a DNA damage
quantification kit (Abcam, Cambridge, MA) according to the
manufacturer’s instructions.
RNA Interference
OEC-M1 cells (16106) were transfected with cytochrome P450
1A1 siRNA (sc-41483) or control siRNA (sc-37007) using
LyoVecTM transfection agent according to the manufacturer’s
protocols (Santa Cruz Biotechnology Inc). After transfection, the
Figure 1. The backbone of the synthesized polyenylpyrroles.
doi:10.1371/journal.pone.0067603.g001
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cells were incubated for 24 h and then subjected to compound 1a
stimulation for further analysis [19].
Ethics Statement
All animal manipulations were performed in the Laboratory
Animal Center of National Ilan University (Ilan, Taiwan) in
accordance with the National Ilan University guide for the care
and use of laboratory animals. The procedures used were
approved by the Animal Care and Use Committee of the National
Ilan University. All manipulations were performed under isoflur-
ane anesthesia, and all efforts were made to minimize suffering.
Antitumor Activity in vivo
Female 6–8-week old congenital athymic BALB/c nude (nu/nu)
mice were used for the experiment (National Laboratory Animal
Center, Taipei, Taiwan). The animals were s.c. implanted with
16107 OEC-M1 cells into the back of mice. When the tumor
reached 80–120 mm3 in volume, animals were divided randomly
into control and test groups consisting of six mice per group (day
0). Daily s.c. administration of compound 1a, dissolved in a
vehicle of 20% Tween 80 in normal saline (v/v) was performed
from days 0 to 4 far from the inoculated tumor sites (.1.5 cm).
The control group was treated with vehicle only. The tumor
volume was determined by measurement of the length (L) and
width (W) of the tumor three times a week and the mice were
weighed at the same time. The tumor volume at day n (TVn) was
calculated as TV (mm3) = (L6W2)/2. The relative tumor volume
at day n (RTVn) versus day 0 was expressed according to the
following formula: RTVn=TVn/TV0. The condition of the mice
did not decline significantly during the experiment and no
significant signs of suffering were observed. The maximal
allowable tumor size is 1000 mm3 beyond which action is taken
to euthanize the mice. The tumor size of one of the control group
mice reached 1012 mm3 at day 28, and at the same day all the
mice were humanely euthanized by inhalation of an overdose of
isoflurane to minimize suffering. Xenograft tumors as well as other
vital organs of treated and control mice were harvested for further
study.
Caspase-3 Activity Assay
Tissues lysates were prepared in lysis buffer (0.25 mM sucrose,
1 mM EDTA, 10 mM Tris and a protease inhibitor cocktail
(Sigma Chemical Co.). The lysates (50 mg protein) were incubated
for 1 h at 37uC in HEPES buffer containing 100 mM concentra-
tions of the specific fluorogenic substrate Ac-DEVD-AMC (BD
Biosciences, Franklin Lakes, NJ). Caspase-3 activity was measured
Figure 2. Characterization of compound 1a-induced apoptotic cell death. (A) Cells were seeded in 96-well plates, treated with compound
1a (1.25 , 40 mM) or vehicle (0.1% DMSO) for 24 and 48 h. Cell viability was measured by AlamarBlueH assays. The data were expressed as mean 6
SD; n = 3. (B) OEC-M1 and HSC-3 cells were treated with compound 1a (5 mM) or vehicle for 24 h, and the DNA breaks were analyzed by flow
cytometry based TUNEL assay. The results are representative of those obtained in three different experiments and the histogram shows the
quantification expressed as the mean 6 SD. *indicates a significant difference at the level of p,0.05. (C) OEC-M1 cells were treated with various
concentrations of compound 1a as indicated, Z-VAD-FMK (50 mM) plus compound 1a (5 mM) or vehicle for 24 h. The cell cycle distribution was
determined by flow cytometry after PI-staining of the nuclei. The data were expressed as mean 6 SD; n = 3. *indicates a significant difference at the
level of p,0.05. (D) OEC-M1 cells were treated with compound 1a (5 mM) or vehicle for the time as indicated. The expression of p-chk2, p53 and p21
were measured by western blotting. The results are representative of those obtained in three different experiments and the histogram shows the
quantification expressed as the mean 6 SD. * and **indicate a significant difference at the level of p,0.05 and p,0.01 respectively.
doi:10.1371/journal.pone.0067603.g002
Table 1. Anticancer Activity of Gymnoconjugatin Derivatives against Human Oral Cancer Cells.
OEC-M1 HSC-3 SAS SCC-4
Samplea R1 R2 R3 Ar 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
1a H H Me 3-chloropyrrol-2-yl 4562b 2962 7162 5062 9062 8563 6064 3863
1b Me H Me 3-chloropyrrol-2-yl 10261 10061 9863 10062 10263 10064 7062 5063
1c nBu H Me 3-chloropyrrol-2-yl 8063 8263 8363 7063 9063 9 062 7263 5562
1d H Me Me 3-chloropyrrol-2-yl 8563 8562 9062 8262 9062 8563 7263 6362
1e Me Me Me 3-chloropyrrol-2-yl 9962 10061 10362 10562 10362 10163 7062 5963
1f Me Et Me 3-chloropyrrol-2-yl 10162 10062 11062 10162 10162 10062 7663 7562
1g nBu Me Me 3-chloropyrrol-2-yl 8862 8063 9863 7862 9262 9062 8063 6063
1h H H H 3-chloropyrrol-2-yl 10663 10563 11563 10263 10162 10562 8863 7963
1i Me H H 3-chloropyrrol-2-yl 10362 10462 10262 10662 9662 10063 8563 7662
1j H H Me 3-chlorothiophen-2-yl 10765 10863 8063 8062 9763 9862 6263 4563
1k Me H Me 3-chlorothiophen-2-yl 10562 10061 10162 10062 10163 10162 8763 8662
1l Me H Me 2-chlorophenyl 10862 10462 10262 9862 10262 10363 9062 7563
1m Me H Me 3-chlorophenyl 11063 10362 10363 10562 9963 10263 8862 8062
1n Me H Me 3-chloro-1-mesyl-pyrrol-2-yl 11665 10966 12066 9966 10063 10162 9366 10062
21 Me H Me H 9562 10062 8863 9063 9863 10362 9062 7963
paclitaxel 5862 5663 7862 5763 9262 9463 6662 4563
aThe concentration of the tested compound is 20 mM; the concentration of paclitaxel is 50 nM.
bThe cell viability are expressed in % of control as mean 6 SD of three independent experiments.
doi:10.1371/journal.pone.0067603.t001
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Figure 3. Compound 1a induces mitochondrial death pathway and caspase-dependent apoptosis. (A) Cells were stimulated with
compound 1a (5 mM) or vehicle (0.1% DMSO) for the time indicated, followed by DiOC2(3) staining. The mitochondrial membrane potential was
analyzed by flow cytometry. The results were expressed as mean 6 SD of mean fluorescence intensity (MFI); n = 3. (B) OEC-M1 cells were stimulated
with compound 1a (5 mM) or vehicle for 16 h, the cytochrome c in mitochondria was measured by flow cytometry. The results were expressed as
mean 6 SD of MFI; n = 3. (C) The cytochrome c in mitochondrial fraction and cytosolic fraction were measured by western blotting. Voltage-
dependent anion channel (VDAC) and actin were used as a marker protein for mitochondria and cytosol respectively. One of three repeated
Anti-Oral Cancer Activity of Polyenylpyrroles
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by monitoring the cleavage of the caspase-3 substrate at excitation
wavelength of 360 nm and emission wavelength of 460 nm,
respectively using a spectrofluorimeter. Activity was expressed as
fluorescence units per milligram of protein per min of incubation.
Statistical Analysis
All values are given as the mean 6 SD. Data analysis was
performed by one-way ANOVA with a subsequent Scheffe’ test.
Results
Characterization of Compound 1a-induced Apoptotic
Cell Death
Compounds 1a-n and 21 at concentration of 20 mM were
evaluated for their cytotoxicities against the human oral squamous
cell carcinoma cell lines: OEC-M1, HSC-3, SAS, and SCC-4 after
24 h and 48 h treatment with AlamarBlueH assay. The anti-cancer
drug paclitaxel was used as a positive control for cell death
induction (Table 1) [20]. As shown in Table 1, compound 1a was
found to be the most potent compound as it exhibited high
cytotoxicity in three cell lines except SAS cells (Cell viability for
48 h compound 1a treatment: OEC-M1:2962%; HSC-
3:5062%; SCC-4:3863%; SAS: 8563%). To further analyze
the cytotoxicity of compound 1a, OEC-M1, HSC-3, SAS, and
SCC-4 cells were incubated with increasing doses of the
compound (1.25–40 mM) or DMSO (0.1%, vehicle control) for
24 and 48 h. As shown in Fig. 2A, compound 1a significantly
inhibited the viability of OEC-M1, HSC-3, and SCC-4 cells with
IC50 of 5 mM, 20 mM, and 1 mM at 48 h, respectively. To gain
further insight into the mode of action of compound 1a, two assays
targeting hallmarks of apoptosis, namely the apoptotic DNA
fragmentation assayed by terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay, and the cell cycle assayed
by flow cytometry after propidium iodide (PI)-staining nuclei were
performed. As shown in Fig. 2B, results from the TUNEL assay
showed that compound 1a induced 3569% and 42611%
TUNEL positive cells in OEC-M1 and HSC-3 cells, respectively,
indicating that compound 1a induces apoptotic DNA fragmenta-
tion in OEC-M1 and HSC-3 cells. In addition, the effect of
compound 1a on the cell cycle distribution in OEC-M1 cells was
determined and the results obtained showed that the cells in G2/
M phase increased in a concentration-dependent manner after
treatment with compound 1a, while concomitantly decreasing the
percentage of cells in G1 and S phase as compared with the
control cells, indicating that compound 1a induces cell cycle arrest
at G2/M phase (Fig. 2C). Moreover, the cells in sub-G1 phase
increased in a concentration-dependent manner after treatment
with compound 1a. However these effects were reduced by the
pan caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-[O-
methyl]-fluoromethylketone (Z-VAD-FMK), indicating that com-
pound 1a induced apoptosis through caspase dependent manner
(Fig. 2C). Compound 1a has a similar effect on the cell cycle
distribution of HSC-3 cells (data not shown). To investigate the
underlying mechanism by which compound 1a treatment induced
cell-cycle arrest at G2/M, we examined the effect of compound 1a
on G2/M phase regulatory proteins, including chk2, p53, and
p21. We found that the phosphorylation level of chk2 was
augmented after 2–4 h treatment with compound 1a (Fig. 2D, top
panel). The expression levels of p53 starts to increase after 4 h of
treatment with compound 1a and continues increasing till 16 h of
treatment. On the other hand, p21 starts to increase at 8 h and
peaks at 16 h after treatment with compound 1a (Fig. 2D, bottom
panel).
Compound 1a Induces Mitochondrial Death Pathway and
Caspase-dependent Apoptosis
Mitochondria play an important role in cell death by changing
its outer and inner membrane permeability and thus leading to
cytochrome c release and caspase activation [21]. To explore
whether compound 1a induced apoptosis via the mitochondrial
signaling pathway, the mitochondrial membrane potential alter-
ation was determined using a mitochondria-specific fluorescence
dye, DiOC2(3). OEC-M1 and HSC-3 cells treated with compound
1a were found to demonstrate a loss of fluorescence intensity with
time (Fig. 3A), indicating that compound 1a induces a loss of
mitochondrial membrane potential. Activation of the mitochon-
drial death pathway can also be identified by the release of
mitochondrial cytochrome c. Cytosolic cytochrome c was detected
by varying the exposure of OEC-M1 cells to compound 1a and
the level of cytochrome c that remained in the mitochondria was
observed to decrease concomitantly (Fig. 3B). The release of
cytochrome c from mitochondria to cytosol was confirmed by
western blotting (Fig. 3C). To get insights into the mechanism of
compound 1a-induced mitochondrial mediated cell death, we
examined the expression of Bcl-2 family proteins including Bcl-2,
Bax and Bcl-2 homologous antagonist killer (Bak). The amount of
anti-apoptotic protein, Bcl-2, was observed to decrease after
treatment with compound 1a (Fig. 3D). In contrast, the expression
of pro-apoptotic protein, Bax and Bak, increased in the presence of
compound 1a (Fig. 3D). As shown in Fig. 3E, compound 1a
induced a decrease of caspase-9 precursor and an increase of
cleaved caspase-3 in a concentration-dependent manner, but
compound 1a did not induce caspase-8 activation. The activation
of caspase-3 was further confirmed by detecting the degradation of
PARP and b-catenin which were cleaved by the active caspase-3
during apoptosis (Fig. 3E).
Compound 1a-induced Apoptosis is Dependent on
Oxidative Stress
To investigate the possible involvement of ROS in compound
1a-induced apoptosis, intracellular ROS stimulated by compound
1a was measured by detecting the fluorescence intensity of 29,79-
dichlorofluorescein, the oxidation product of 29,79-dichlorofluor-
escein diacetate. OEC-M1 cells stimulated with compound 1a
exhibited a rapid increase in the fluorescent product 29,79-
dichlorofluorescein which resulted in the relative fluorescence
intensity peaking at 60 min (Fig. 4A). We next investigated
whether ROS plays a role in compound 1a-induced apoptosis. We
found that antioxidant N-acetylcysteine (NAC) decreased com-
pound 1a-mediated sub-G1 phase increase in OEC-M1 cells
(Fig. 4B). NAC, but not pan caspase inhibitor Z-VAD-FMK and
NADPH oxidase inhibitor diphenyleneiodonium (DPI), partially
prevented the loss of mitochondrial membrane potential induced
by compound 1a (Fig. 4C).
experiments was shown. (D) OEC-M1 cells were treated with various concentration of compound 1a as indicated or vehicle for 24 h. The expression
levels of Bcl-2, Bax and Bak were measured by western blotting. (E) OEC-M1 cells were treated with various concentration of compound 1a as
indicated or vehicle for 24 h. The expression levels of caspase 3 precursor, cleaved caspase 3, caspase 9 precursor, caspase 8 precursor, PARP and b-
catenin were measured by western blotting. In (D) and (E), the results are representative of those obtained in three different experiments and the
histogram shows the quantification expressed as the mean6 SD. *indicates a significant difference at the level of p,0.05 compared to control group.
doi:10.1371/journal.pone.0067603.g003
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Compound 1a-induced Apoptosis and DNA Damage
through Cytochrome P450
We further investigated which intracellular ROS-generating
enzymes were involved in compound 1a-mediated apoptosis.
OEC-M1 cells were stimulated with compound 1a in the presence
or absence of NAC (scavenger of ROS regardless of the source of
production), ketoconazole (cytochrome P450 inhibitor), apocynin
(NADPH oxidase inhibitor), DIDS (mitochondrial inner mem-
brane anion channel inhibitor), rotenone (mitochondrial complex I
inhibitor), L-NAME (iNOS inhibitor), allopurinol (xanthine
oxidase inhibitor), and indomethacin (cyclooxygenase inhibitor)
for 30 min, and then the cell cycle distribution was determined.
We found that NAC and ketoconazole not only decreased the cells
in sub-G1 phase induced by compound 1a (Fig. 5A), but also
reduced the compound 1a-induced increase in ROS generation
(Fig. 5B). Since compound 1a induces ROS generation, this
prompted us to investigate whether compound 1a damages DNA.
Using the apurinic/apyrimidinic (AP) sites formation assay, we
found that compound 1a causes DNA damage and the damage is
decreased by NAC and ketoconazole (Fig. 5C). NAC and
ketoconazole were also found to modulate G2/M phase regulatory
proteins by reducing phosphorylation level of Chk2 and by
reducing the expression levels of cyclin B1 and p21 in compound
1a-stimulated OEC-M1 cells (Fig. 5D). In addition, ketoconazole
inhibited both cytochrome P450 1A1 and 3A4, and we further
found that resveratrol (cytochrome P450 1A1 inhibitor) decreased
sub G1 increase induced by compound 1a more significantly than
itraconazole (cytochrome P450 3A4 inhibitor) (Fig. 5E). Since
resveratrol is not a specific inhibitor to cytochrome P450 1A1, the
role of cytochrome P450 1A1 on compound 1a-mediated effects
was confirmed by siRNA. Knocking down the expression of
cytochrome P450 1A1 by siRNA (Fig. 5F) was shown to decrease
compound 1a-mediated ROS production (Fig. 5G) and cytotox-
icity (Fig. 5H).
Anti-tumor Activity of Compound 1a in vivo
Results obtained show that compound 1a inhibited the growth
of tumor (Fig. 6A). The tumor tissues from compound 1a treated
mice displayed an increase in caspase 3 activity compared to that
from vehicle treated mice, whereas the caspase-3 activity in the
liver, kidney, and spleen of compound 1a treated or vehicle
treated mice was not increased (Fig. 6B). Additionally the changes
in body weight of the compound 1a-treated mice were similar to
that of the vehicle-treated mice (Fig. 6C).
Discussion
In our previous study [13], the most potent gymnoconjugatin
derivatives against human lung cancer A549 cells was compound
1g (IC50 values of 0.01 mM); however, in the present study,
compound 1g did not showed potent cytotoxicity against OSCC.
Compound 1a was identified as the most potent compound
against OSCC. The loss of activity against OSCC in compounds
1j–1n, where other chloro-substituted aromatic rings were present
instead of 3-chloropyrrole, indicated that the later group played an
important role in effecting cytotoxicity. In addition, the lack of
cytotoxicity in compounds 1h and 1i also illustrated the
importance of a methyl group at the R3 position. Similar to our
Figure 4. Compound 1a-induced apoptosis is dependent on
oxidative stress. (A) OEC-M1 cells were incubated with 29,79-
dichlorofluorescein diacetate (2 mM) for 30 min, followed by compound
1a (5 mM) or vehicle (0.1% DMSO) treatment for the time indicated. The
relative mean fluorescence intensity (MFI) of 29,79-dichlorofluorescein
was detected at an excitation wavelength of 485 nm and an emission
wavelength of 530 nm with a fluorometer; n = 3. (B) OEC-M1 cells were
incubated with N-acetyl-cysteine (NAC) (10 mM) or Z-VAD-FMK (50 mM)
for 30 min, followed by compound 1a (5 mM) or vehicle treatment for
24 h. The cell cycle distribution was determined by flow cytometry after
PI-staining of nuclei. The data were expressed as mean 6 SD; n= 3. (C)
OEC-M1 cells were incubated with NAC (10 mM), Z-VAD-FMK (50 mM),
or DPI (25 mM) for 30 min, followed by compound 1a (5 mM) or vehicle
treatment for 16 h. The mitochondrial membrane potential was
analyzed by flow cytometry using DiOC2(3) staining. The data are
expressed as mean6 SD of MFI; n = 3. *indicates a significant difference
at the level of p,0.05.
doi:10.1371/journal.pone.0067603.g004
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Figure 5. Compound 1a-induced apoptosis and DNA damage through cytochrome P450. (A) OEC-M1 cells were incubated with NAC
(10 mM), ketoconazole (KTZ, 50 mmM), diisothiocyanatostilbene-disulfonic acid (DIDS, 10 mM), apocynin (0.3 mM), rotenone (1 mM), L-NAME (500 mM),
allopurinol (100 mM), indomethacin (50 mM) for 30 min, followed by compound 1a (5 mM) or vehicle (0.1% DMSO) treatment for 24 h. The cell cycle
distribution was determined by flow cytometry after PI-staining of nuclei. (B) OEC-M1 cells were incubated with KTZ (50 mM) and NAC (10 mM) in the
presence of 29,79-dichlorofluorescein diacetate (2 mM) for 30 min, followed by compound 1a (5 mM) or vehicle (0.1% DMSO) treatment for 30 min,
and then the ROS production was measured. (C) OEC-M1 cells were incubated with NAC (10 mM) or ketoconazole (KTZ, 50 mM) for 30 min, followed
by compound 1a (5 mM) or vehicle treatment for the time as indicated. AP sites of DNA lesions were analyzed by a DNA damage quantification kit.
(D) OEC-M1 cells were treated with NAC (10 mM) or ketoconazole (KTZ, 50 mM) for 30 min, followed by compound 1a (5 mM) or vehicle (0.1% DMSO)
treatment for 2 or 16 h. The expression levels of p-chk2 (2 h), cyclin B1, p21, and p-cdc2 were measured by western blotting. (E) OEC-M1 cells were
incubated with resveratrol (100 mM) or itraconazole (10 mM) for 30 min, followed by compound 1a (5 mM) or vehicle treatment for 24 h. The cell cycle
distribution was determined by flow cytometry after PI-staining of nuclei. (F) Untreated OEC-M1 cells, cytochrome P450 1A1 siRNA transfected OEC-
M1 cells, and control siRNA transfected OEC-M1 cells were incubated with compound 1a (5 mM) or vehicle for 24 h and then the cytochrome P450
1A1 expression were measured by western blotting. (G) Untreated OEC-M1 cells, cytochrome P450 1A1 siRNA transfected OEC-M1 cells, and control
siRNA transfected OEC-M1 cells were incubated with compound 1a (5 mM) or vehicle for 30 min and then the ROS production was measured. (H)
Untreated OEC-M1 cells, cytochrome P450 1A1 siRNA transfected OEC-M1 cells, and control siRNA transfected OEC-M1 cells were incubated with
compound 1a (5 mM) or vehicle for 24 h. The cell number was determined by trypan blue staining. In (A), (B), (C), (E), (G) and (H), the data are
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previous study, compounds 1j-1n, 1h and 1i did not show
cytotoxicity against A549 cells [13]. The similarity between
compounds 1a and 1b suggests that they might show similar
cytotoxicity. Compounds 1a and 1b showed cytotoxicity against
A549 cells with IC50 values of 0.6 mM and 1.2 mM respectively
[13]; interestingly, compound 1b lacks cytotoxicity against OEC-
M1 and HSC-3 cells. These results indicated that having a
hydrogen at the R1 position is important for its cytotoxicity against
OEC-M1 and HSC-3 cells. The relation between chemical
structure and cell-type specificity needs to be further investigation.
Four OSCC cell lines were used in this study, OEC-M1 cells were
an indigenous oral cancer cell line in Taiwan with a p53 point
mutation at codon 173 (V to L) and were more sensitive to
radiation, but more resistant to chemotherapy [22,23]. The SCC-
4 cell line expresses and accumulates p53 with a missense
mutation/point mutation in position 151, whereas HSC-3 lacks
p53 [24]. SAS cells have a point mutation in one p53 allele, but it
has been shown to possess an ability to induce p53-dependent
signal transduction [25]. The viability of OEC-M1 cells, SCC-4
cells, and HSC-3 cells were all reduced by compound 1a;
however, the killing effect of compound 1a on these cell lines
might not be mediated by p53. In contrast to OEC-M1 cells, SAS
cells have a high level expression of EGFR [26], and is resistant to
TRAIL-induced apoptosis [27]. In this study, SAS cells were
shown to be resistant to compound 1a treatment and we have yet
to find the cause for this resistance.
Intracellular ROS accumulation is involved in the induction of
apoptosis by various cytotoxic agents [28]. In the present study,
ROS was demonstrated to be pro-apoptotic in compound 1a-
treated oral cancer OEC-M1 cells by showing a protective effect of
antioxidants on DNA damage, mitochondrial membrane potential
loss, and apoptosis. In contrast, ROS played an anti-apoptotic and
protective role in compound 1a-treated lung cancer A549 cells
[13]. The role of oxidative stress in apoptosis is controversial and
could be stimulus and cell type dependent [29,30]. ROS are
mainly produced by mitochondria and NADPH oxidase; however,
inhibitors of mitochondria and NADPH oxidase did not reduce
compound 1a-induced apoptosis. Cytochrome P450 superfamily is
a diverse group of enzymes that catalyzes the oxidation of various
substances and is involved in drug metabolism (either directly or
by facilitated excretion from the body) and bioactivation
(transforming into their active compounds) [31]. For example,
cytochrome P450 1A1 is involved in the metabolic activation of
aromatic hydrocarbons, such as benzo(a)pyrene, by transforming it
to carcinogen BP-7,8-dihydrodiol-9,10-epoxide [32]. ROS gener-
ated by cytochrome P450 1A1 contributes to carcinogenesis
[33,34], hypertension [35], and tissue damage [36]. In the present
study we found that cytochrome P450 1A1 played a pro-apoptotic
role in compound 1a-treated OEC-M1 cells. The pro-apoptotic
effect of cytochrome P450 might proceed via the transformation of
compound 1a to a more toxic compound or through the
production of ROS. It has been suggested that cytochrome P450
1A1 promotes DNA damage and G2/M arrest in benzo[a]pyrene-
stimulated breast carcinoma MCF-7 cells [37]. In contrast,
cytochrome P450 1A1 is able to detoxify toxins, for examples, it
plays a protective role in benzo[a]pyrene-induced oral cancer in
mice [38] and in arsenic toxicity in rat liver cells by reducing
apoptosis [39]. Cytochrome P450 1A1 polymorphism on exon 7
has also be shown to be capable of modifying the susceptibility to
oral cancer among Asians [40].
The anti-cancer activity of the p53 protein has been demon-
strated by its ability to induce apoptosis in response to a variety of
expressed as mean 6 SD of three independent experiments, while, in (D) and (F), the results are representative of those obtained in three different
experiments and the histogram shows the quantification expressed as the mean 6 SD. *indicates a significant difference at the level of p,0.05.
doi:10.1371/journal.pone.0067603.g005
Figure 6. Inhibition of human oral cancer xenografts growth
in vivo by compound 1a. (A) OEC-M1 tumor-bearing mice were
administered s.c. with vehicle control (e), 15 mg/kg (g), or 30 mg/kg
(6) compound 1a on days 0–4 for 5 days. The figure showed the
relative tumor volume of control and compound 1a-treated groups. (B)
Caspase 3 activity of tissues from OEC-M1 tumor-bearing mice (on day
28 after inoculation). (C) The changes of body weight of the tumor-
bearing mice. Body weight was measured for each animal every three
days starting from the day of the initial compound 1a treatment. All
results are given as means 6 SD; n= 6 for each group.*indicates a
significant difference at the level of p,0.05.
doi:10.1371/journal.pone.0067603.g006
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cellular stresses including anti-cancer drugs. P53 promotes
apoptosis through down-regulating Bcl-2 protein expression and
up-regulating BAX protein expression at transcriptional level
[41,42]. P53 also promotes mitochondrial apoptosis by activating
BAK protein [43]. Our data revealed that the protein levels of p53
and p21 were increased by compound 1a. These suggest that p53
activation may be involved in compound 1a-mediated apoptosis
which in turn regulates Bcl-2 family protein expression. However,
in the present study we should not rule out the possibility for
compound 1a-induced increase in p21 expression and the changes
in the Bcl-2 family protein expression in OEC-M1 cells would then
occur in a p53-independent manner.
In the present study we clearly demonstrated that compound 1a
is efficacious against OSCC cells both in cell culture and animal
models. Mechanistic studies suggested that compound 1a causes
DNA damage by enhancing intracellular ROS level which leads to
cell cycle arrest and apoptotic cell death. The latter phenomenon
is also partially dependent on cytochrome P450 1A1 (Fig. 7).
Considering the limited therapeutic options available against
OSCC, results from the present study provides a molecular
rationale for the translation of compound 1a into a potential
therapeutic against OSCC.
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